A dabigatran reversal agent
Idarucizumab
An emergency antidote that quickly reverses the blood-thinning effect of dabigatran.
What is Idarucizumab?
Idarucizumab is an antibody fragment used to rapidly reverse the blood-thinner dabigatran. It is given by injection in hospital when someone on dabigatran has life-threatening or uncontrolled bleeding, or needs emergency surgery or an urgent procedure that cannot wait. By binding tightly to dabigatran, it switches off its blood-thinning effect within minutes. It is a specialist emergency medicine given by trained staff, not something used at home. Its brand name is Praxbind.
Education and reference only. This is a plain-language guide to Idarucizumab — it deliberately contains no doses. Doses depend on the person, the brand and the reason for treatment, and belong with your prescriber. Always check the BNF, the product labelling (SmPC) and follow medical advice.
What it is
Idarucizumab is a reversal agent, a piece of an antibody designed to grab hold of the blood-thinner dabigatran and neutralise it. It is given by injection into a vein in hospital, in emergencies where dabigatran's blood-thinning effect needs to be stopped quickly. This includes serious or uncontrolled bleeding, or the need for urgent surgery or another procedure where bleeding would be dangerous. It only reverses dabigatran and has no effect on other blood thinners.
How it works
Dabigatran thins the blood by blocking a key clotting protein called thrombin. Idarucizumab binds very tightly to dabigatran, holding onto it far more strongly than dabigatran holds onto thrombin. This pulls dabigatran away from the clotting process so that normal clotting can resume, usually within minutes. The effect is specific to dabigatran, so the person's natural ability to clot is restored without adding any clotting medicines of their own.
Company & origin
Originated / developed by: Boehringer Ingelheim.
A specialist reversal medicine used in UK hospitals to rapidly switch off the blood-thinner dabigatran.
Practical use
How to take Idarucizumab
General, dose-free guidance — always follow your prescriber's and the leaflet's specific instructions.
- It is given as an injection or infusion into a vein by trained healthcare professionals in hospital.
- It is used in emergencies only, for serious bleeding or urgent surgery while you are on dabigatran.
- Tell the team about all the blood thinners and other medicines you take so the right reversal approach is chosen.
- After the emergency, your team will discuss when it is safe to restart a blood thinner, as your original risk of clots remains.
- Report any rash, breathlessness or swelling during or after the injection, which could signal an allergic reaction.
Weighing it up
Advantages & disadvantages of Idarucizumab
Advantages
- Reverses the effect of dabigatran rapidly, usually within minutes, in an emergency.
- Highly specific, so it neutralises dabigatran without adding clotting medicines.
- Allows urgent surgery or control of serious bleeding in people taking dabigatran.
Disadvantages
- Only reverses dabigatran and has no effect on other blood thinners.
- Once dabigatran is reversed, the person's underlying clot risk returns and may need a blood thinner restarted.
- Can rarely cause allergic reactions and is only available in hospital settings.
Practical use
Good to know
Idarucizumab is an emergency, hospital-only treatment used in two main situations: life-threatening or uncontrolled bleeding in someone taking dabigatran, and the need for an urgent operation or procedure that cannot be delayed. It is very specific and only reverses dabigatran; it will not reverse other anticoagulants such as warfarin, apixaban or rivaroxaban. Once the emergency is over, the underlying reason the person was taking dabigatran (such as preventing stroke in atrial fibrillation or treating a clot) does not go away, so they remain at risk of clotting and a plan is made about restarting a blood thinner when it is safe. Allergic reactions can occur, and the team watches for these.
Who should not take it / use with caution
- It is not useful for people whose bleeding is due to anticoagulants other than dabigatran.
- Used with care in people with a known allergy to idarucizumab or its ingredients.
- Its use is limited to emergency, hospital settings under specialist supervision.
Monitoring
- Watching for control of bleeding and the person's overall condition after it is given.
- Checking clotting tests where appropriate to confirm the effect of dabigatran has been reversed.
- Reviewing when it is safe to restart a blood thinner, as the original clot risk remains.
Side effects
- It is generally well tolerated, as it simply binds and removes dabigatran.
- Possible allergic-type reactions such as rash, breathlessness or swelling.
- After reversal, the return of the underlying clot risk if a blood thinner is not restarted when safe.
Key interactions
- It acts only on dabigatran and does not interact with other blood thinners, which it cannot reverse.
- It does not interfere with other routine medicines in a clinically important way.
- Decisions about restarting anticoagulation afterwards are made by the specialist team.
Available as: Solution for injection or infusion into a vein, given by healthcare professionals.
Answers
Idarucizumab: frequently asked questions
What is idarucizumab used for?
It is an emergency antidote that rapidly reverses the blood-thinner dabigatran, used in hospital for life-threatening bleeding or before urgent surgery in people taking dabigatran.
How quickly does it work?
It binds dabigatran tightly and usually reverses its blood-thinning effect within minutes.
Does it reverse other blood thinners?
No. It is specific to dabigatran and does not reverse warfarin, apixaban, rivaroxaban or other anticoagulants.
Will I need to restart my blood thinner afterwards?
Often yes. The reason you were taking dabigatran, such as preventing stroke or treating a clot, remains, so your team will plan when it is safe to restart anticoagulation.
Can it cause a reaction?
It is generally well tolerated, but allergic-type reactions can occur, so the team watches for any rash, breathlessness or swelling.
Authoritative sources
- BNF
- NICE CKS
Building a medicines information resource?
We create evidence-led, dose-free drug and formulary references for teams.